At least 11 employees working at the FDA's Center for Devices and Radiological Health - which oversees medical device reviews ...

The current state of health services highlights crucial sectors facing disruptions and developments, from US foreign aid freezes affecting disease control supply chains, to the FDA's actions on new ...

The U.S. Food and Drug Administration is asking some of its recently fired scientists if they will come back to their jobs, ...

The US foreign aid freeze causes disruption in the supply chain for vital medical products in poorer countries, affecting diseases like HIV and malaria. Other health updates include FDA drug approvals ...

The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk’s popular weight-loss and ...

Esperion Therapeutics has two approved LDL-C lowering therapies, Nexletol and Nexlizet, but lacks a strong pipeline for future growth.

Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...

In Robert F. Kennedy Jr.’s first interview as secretary of the Department of Health and Human Services, he made multiple ...

The FDA has now resolved the shortages of Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...

The U.S. Food and Drug Administration approved Mirum Pharmaceuticals' genetic disorder drug on Friday, making it the first ...

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration ...